Human cathepsin D

Folia Histochemica et Cytobiologica

Volumn 46, Issue 1, 2008, Pages 23-38

  Minarowska, Alina ^a   Gacko, Marek ^a   Karwowska, Alicja ^a   Minarowski, Łukasz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Aspartic proteinase; Cathepsin D; Preprocathepsin D; Procathepsin D

Indexed keywords

CATHEPSIN D; PROTEINASE; SOMATOMEDIN B RECEPTOR;

ALZHEIMER DISEASE; BIOCHEMISTRY; CATALYSIS; CELL MEMBRANE TRANSPORT; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE LOCATION; HUMAN; INFLAMMATORY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR MECHANICS; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; RHEUMATIC DISEASE; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; CATHEPSIN D; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBSTRATE SPECIFICITY;

EID: 41649096358     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0003-x     Document Type: Review

References (172)

1. Hedin SG. Investigation on the proteolytic enzymes of the sleen of the ox. J Physiol. 1904;30:155-157.
2. Wilstätter R, Bamann E. Üler die proteasen der magenschleimhaut. Erste abhandlung über die enzyme der leukocyten. Z Physiol Chem. 1928;180:127-143.
3. Anson ML. The estimation of cathepsin with hemoglobin and partial purification of cathepsin. J Gen Physiol. 1937;20:565-574.
4. Tallan HH, Jones ME, Fruton JS. On the proteolytic enzymes of animal tissue. X. Beef spleen cathepsin C. J Biol Chem. 1952;194:793-805.
5. De Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F. Tissue fractionation studies. 6. Intracellular distribution pattern of enzymes in rat liver tissue. Biochem J. 1955; 60:604-617.
6. Czystohorski T. Pepsin or cathepsin? Pol Tyg Lek. 1955;10:9 41-943.
7. Press EM, Porter RR, Cebra J. The isolation and properties of a proteolytic enzyme, cathepsin D, from booine spleen. Biochem J. 1960;74:501-514.
8. Redecker B, Heckendorf B, Grosch HW, Mersmann G, Hasilik A. Molecular organization of the human cathepsin D gene. DNA Cell Biol. 1991;10:423-431.
9. May FE, Smith DJ, Westley BR. The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point. Gene. 1993;134:277-282.
10. Scorborongh PE, Richo GR, Kay J, Conner GE, Dunno BM. Comparison of kinetic properties of native and recombinand human cathepsin D. Adv Exp Med Biol. 1991;306: 343-347.
11. Sheikh MS, Augereau P, Chalbos D, Garcia M, Rochefort H. Retinoid regulation of human cathepsin D gene expression. J Steroid Biochem Molec Biol. 1996;57:283-291.
12. Wang F, Duan R, Chirgwin J, Safe SH. Transcriptional activarion of cathepsin D gene expression by growth factors. J Med Endocrinol. 2000;24:193-202.
13. Devasagayam TPA, Pushpendran CK, Eapen J. Cycloheximide-induced inhibition of cathepsin D activity in suckling and adult rats. Biochem Int. 1981;3:55-60.
14. Musi M, Tessitore L, Bonelli G, Kazakova OV, Baccino FM. Changes in rat liver immunoreactive cathepsin D after cycloheximide. Biochem Int. 1985;10:283-290.
15. Stancikova M, Frysak Z, Trnavsky K. Effect of colchicine on the activity of cathepsin B and D in liver cirrhosis. Acta Med Hung. 1987;44:181-188.
16. Yamamoto K. Cathepsin E and cathepsin D. In: Turk V, ed. Proteases. New perspectives. Birkhäuser Verlag Basel. 1999:59-71.
17. Huang JS, Huang SS, Tang J. Cathepsin D isozymes from porcine spleens. Lagre scale purification and polypeptide chain arrangements. J Biol Chem. 1979;254:11405-11417.
18. Ikeda K, Suzuki H, Okano T, Nakagawa S. Human spleen cathepsin D: its characterization and localization in human spleen. Int J Biochem. 1989;21:317-326.
19. Kregar I, Urh I, Smith R, Umezawa H, Turk V. Isolation of cathepsin D on pepstatin-agarose resin. In: Turk V, Marks N, eds. Intracellular protein catabolism II. Plenum Press NY. 1977:250-254.
20. Stewart AJ, Piggott NH, May FEB, Westley BR. Mitogenic activity of procathepsin D purified for conditioned medium of breast cancer cells by affinity chromatography on pepstatinyl agarose. Int J Cancer. 1994;57:715-718.
21. Gubensek F, Barstow I, Kregar I, Turk V. Rapid isolation of cathepsin D by affinity chromatography on the immobilized synthetic inhibitor. FEBS Lett. 1976;71:42-44.
22. Gacko M, Minarowska A, Karwowska A, Minarowski Ł. Cathepsin D inhibitors. Folia Histochem Cytobiol. 2007;45: 291-313.
23. Smith R, Turk V. Cathepsin D: rapid isolation by affinity chromatography on hemoglobin-agarose resin. Eur J Biochem. 1974;48:245-254.
24. Wittlin S, Rösel J, Stover DR. One-step purification of cathepsin D by affinity chromatography using immobilized propeptide sequences. Eur J Biochem. 1998;252:530-536.
25. Conner GE. Isolation of procathepsin D from mature cathepsin D by pepstatin affinity chromatography. Antocatalytic proteolysis of the zumogen from of the enzyme. Biochem J. 1989;263:601-604.
26. Beyer MB, Dunn BM. Self-activation of recombinant human lysosomal procathepsin D at a newly engineered cleavage junction, "short" pseudocathepsin D. J Biol Chem. 1996;271:15590-15596.
27. Conner GE, Udey JA. Expression and refolding of recombinant human fibroblast procathepsin D. DNA Cell Biol. 1990;9:1-9.
28. Gopalakrishan MM, Gosch HW, Locatelli-Hoops S, Werth N, Smolenova E, Nettersheim M, Sandhoff K, Hasilik A. Purified recombinant human prosoposin forms oligomers that bind procathepsin D and affeet its autoactivation. Biochem J. 2004;383:507-515.
29. Barrett AJ. Cathepsin D. Purification of isoenzymes from human and chicken liver. Biochem J. 1970;117:601-607.
30. Barrett AJ. Human cathepsin D. Adv Exp Med Biol. 1979;95:291-300.
31. Fusek M, Baudys M, Metcolf P. Purification and crystallization of human cathepsin - D. J Mol Biol. 1992;226:555-558.
32. Gulnik S, Baldwin ET, Tarasova N, Erickson J. Human liver cathepsin D. Purification, crystallization and preliminary Xray diffraction analysis of a lysosomal enzyme. J Mol Biol. 1992;227:265-270.
33. Koelsch O, Metcalf P, Vetvicka V, Fusek M. Human pro-cathepsin D: three-dimensional model and isolation. Adv Exp Med Biol. 1995;362:273-278.
34. Afting EG. Becler ML. Two-step affinity-chromatographic purification of cathepsin D from pig myometrium with high yield. Biochem J. 1981;197:519-522.
35. Contractor SF, Manson RM, Oakey M. Purification and properties of human placental cathepsin D. Placenta. 1982;3:45-56.
36. Pohl J, Bures L, Slavik K. Isolation and characterization of cathepsin D from human gastric mucosa. Coll Chech Chem Commun. 1981;46:3302-3313.
37. Azaryan A, Akopyan T, Buniatian H. Cathepsin D from human train: purification and multiple forms. Biomed Biochim Acta. 1983;42:1237-1246.
38. Lundblad G, Bernbäck ML, Widemann C. Proteolytic activity in human thyroid extracts. I. Purification and properties of some proteinases. Acta Cem Scand. 1966;20:675-688.
39. Ishikawa I, Cimasoni G. Isolation of cathepsin D from human leucocytes. Biochim Biophys Acta. 1977;480:228-240.
40. Metcalf P, Fusek M. Two crystal structure for cathepsin D: the lysosomal targeting signal and active site. EMBO J. 1993;12:1293-1302.
41. Pain RH, Lah T, Turk V. Dematuration studies of aspartic proteinases. Biochem Soc Transact. 1985;13:1032-1035.
42. Turk V, Kregar I, Gubensek F, Lapanje S, Urh I, Kovacic M. Studies of bovine spleen cathepsin D. Acta Biol Med. 1977;36:1531-1535.
43. Erickson AH. Biosynthesis of lysosomal endopeptidases. J Cell Biochem. 1989;40:31-41.
44. Fusek M, Vetvicka V. Cathepsin D. In: Fusek M, Vetvicka V, eds. Aspartic proteinases: physiology and patology. CRC Press Boca Ratton. 1995:143-184.
45. Giselmann V, Hasilik A, von Figura K. Processing of human cathepsin D in lysosomes in vitro. J Biol Chem. 1985;260: 3215-3220.
46. Gieselmann VR, Pohlmann A, Hasilik A, Figura K. Biosynthesis and transport of cathepsin D in cultured human fibroblast. J Cell Biol. 1983;97:1-5.
47. hasilik A. The early and late processing of lysosomal enzymes: proteolysis and compartmentation. Experientia. 1992;48:130-151.
48. Schulze-Lohoff E, Hasilik A, Figura K. Cathepsin D precursors in clathrin-coated organelles from human fibroblast. J Cell Biol. 1985;101:824-829.
49. Fortenberry SC, Schorey JS, Chirgwin JM. Role of glycosylation in the expression of human procathepsin D. J Cell Sci. 1995; 108:2001-2006.
50. Imperiali B, Rickert KW. Conformational implications of asparagines-linked glycosylation. Proc Natl Acad Sci USA. 1995;92:97-101.
51. Shewale JG, Rakahashi T, Tang J. The primary structure of cathepsin D and the implications for its biological functions. In: Kostka V, ed. Aspartic proteinases and their inhibitors. Walter de Gruyter Berlin. 1985:101-116.
52. Isidoro C, Hummel M, Baccino F, Hasilik A. The respective role of mannose-6-phosphate residues and of prosaposin in the segregation of lysosomal procathepsin D. In: Hopsu-Havu VK, ed. Proteolysis in cell function. IOS Press Amsterdam. 1997:234-241.
53. Baranski TJ, Cantor A, Kornfeld S. Lysosomal enzyme phosphorylation I. Protein recognition determination in both lobes of procathepsin D mediate its interaction with UDP-GlcNac: lysosomal enzyme N-acetylglucosamine-1-phosphotransferase. J Biol Chem. 1992;267:23342-23348.
54. Cantor S, Kornfeld S. Phosphorylation of Asn-linked oligosaccharides located at novel sites on the lysosomal enzyme cathepsin D. J Biol Chem. 1992;267:23357-23363.
55. Boker C, von Figura K, Hille-Rehfeld A. The carboxy-terminal peptides of 46 kDa and 300 kDa mannose 6-phosphate receptors share partial sequence homology and contain information for sorting in the early endosomal pathway. J Cell Sci. 1997;110:1023-1032.
56. Conner GE. The role of the cathepsin D propeptide in sorting to the lysosome. J Biol Chem. 1992;267:21738-21745.
57. Grassel S, Hasilik A. Human cathepsin D precursor is associated with a 60 kDa glycosylated polypeptide. Biochim Biophys Res Commun. 1992;18:276-282.
58. Hasilik A, Klein U, Waheed A, Strecker G, von Figura K. Phosphorylated oligosaccharides in lysosomal enzymes: indutification of α-N-acetyloglucosamine(1)phosphor(6) mannose diester groups. Proc Natl Acad Sci USA. 1980;77: 7074-7078.
59. Hasilik A, Neufeld EF. Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylotion of mannose residues. J Biol Chem. 1989;255:4946-4950.
60. Sahagian GG. The mannose 6 phosphate receptor: function, biosynthesis and translocation. Biol Cell. 1984;51:207-214.
61. Hille-Rehfeld A. Mannose-6-phosphate receptors in sorting and transport of lysosomal enzymes. Biochim Biophys Acta. 1995;1241:177-104.
62. Horst M, Mares M, Zabe M, Hummel M, Wiedernders B, Kirsche H, Hasilik A. Synthesis phosphorylated oligosaccharides in lysosome in enhanced by fusion to cathepsin D. J Biol Chem. 1993;268:19690-19696.
63. Erickson AH, Conner GE, Bloble G. Biosynthesis of a lysosomal enzyme. Partial structure of two transient and functionally distinct NH2-terminal sequences in cathepsin D. J Biol Chem. 1981;256:11224-11231.
64. Faust PL, Kornfeld S, Chirgwin JM. Cloning and sequence analysis of cDNA for human cathepsin D. Proc Natl Acad Sci USA. 1985;82:4910-4914.
65. Kobayashi T, Honke K, Gasa S, Fujii T, Maguchi S, Miyazaki T, Makita A. Proteolytic processing sites producing the mature from of human cathepsin D. Int J Biochem. 1992;24: 1487-1492.
66. Lah T, Turk V. Autolysis studies of cathepsin D. Hoppe-Seyler's Z Physiol Chem. 1982;363:247-254.
67. Wittlin S, Rosel J, Hofmann F, Stover DR. Mechanism and kinetics of procathepsin D activation. Eur J Biochem. 1999; 265:384-393.
68. Yonezawa S, Takahashi T, Wang X, Wong RNS, Hartsuck JA, Tang J. Structure at the proteolytic processing region of cathepsin D. J Biol Chem. 1988;263:16504-16511.
69. Richio G, Conner GE. Proteolytic activation of human pro-cathepsin D. Adv Exp Med Biol. 1991;306:289-296.
70. Samarel AM, Ferguson AG, Decker RS, Lesch M. Effects of cysteine protease inhibitors on rabbit cathepsin D maturation. Am J Physiol. 1989;257:C1069-C1079.
71. Richo GR, Conner GE. Structural requirements of procathepsin D activation and maturation. J Biol Chem. 1994;269: 14806-14812.
72. Sapolsky AI, Woessner JF. Multiple forms of cathepsin D from bovine uterus. J Biol Chem. 1972;247:2069-2076.
73. Fortenberry SC, Chirgwin JM. The propeptide is nonessential for the expression of human catepsin D. J Biol Chem. 1995;270:9778-9782.
74. Scarborough PE, Dunn BM. Redesign of the substrate specificity of human cathepsin D: the dominant role of position 287 in the S2 subside. Protein Eng. 1994;7:495-502.
75. Van Noort JM, van der Drift ACM. The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes. J Biol Chem. 1989;264:14159-14164.
76. Ferguson JB, Andrews JR, Voynick IM, Fruton JS. The specificity of cathepsin D. J Biol Chem. 1973;248:6701-6708.
77. Scarborough PE, Guruprasad K, Topham C, Richo GR, Conner GE, Blundell TL, Dunn BM. Exploration of subside binding specificity of human cathepsin D trough kinetics and rule-based molecular modeling. Prot Sci. 1993;2:269-276.
78. Kussendrager KD, Jong Y, Bouma JMW, Gruber M. The digestion of the B chain of oxidized insulin by extracts of rat liver lysosomes. Biochim Biophys Acta. 1972;279:75-86.
79. Worowski K, Ostrowska H. Cathepsin D. Post Biol Kom. 1980;7:119-147.
80. Hunt LT, Dayhoff O. The occurence in proteins of the tripeptides Asn-X-Thr and Asn-X-Ser and bound carbohydrate. Biochem Biophys Res Commun. 1970;39:757-765.
81. Bjelic S, Aqvist J. Catelysis and linear free energy relationships in aspartic proteases. Biochemistry. 2006;45:7709-7723.
82. Conner GE, Richo G. Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D. Biochemistry. 1992;31:1142-1147.
83. Cooper JB. Aspartic proteinases in disease: a structural perspective. Curr Drug Targets. 2002;3:155-173.
84. Nduwimana J, Guenet L, Dorval I, Blayau M, Le Gall JY, Le Treut A. Proteases. Ann Biol Clin. 1995;53:251-264.
85. Veerapandian B, Cooper JB, Sali A, Blundell TL, Rosati RL, Dominy BW, Damon DB, Hoover DJ. Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases. Protein Sci. 1992;1:322-328.
86. Xie D, Gulnik S, Collins L, Gustchina E, Suvorov L, Erickson JW. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues. Biochemistry. 1997;36:16166-16172.
87. Huber R, Bennett WS. Enzymes as biological catalysts. In: Hoppe, Lohmann W, Markl H, Ziegler H, ed. Biophysics. Springer-Verlag, Berlin. 1983:372-384.
88. Jencks WP. Economics of enzyme catalysis. Cold Spring Harbor Symp Puant Biol. 1987;52:65-73.
89. Majer P, Collins JR, Gulnik SV, Erikson JW. Structural-based specificity mapping of human cathepsin D using statine-based inhibitors. Prot Sci. 1997;6:1458-1466.
90. Dionyssiou-Asteriou A, Rakitzis ET. Activation of cathepsin D by glycine ethyl ester. Biochem J. 1979;177:355-356.
91. Watabe S, Yago N. Phospholipids activate cathepsin D. Biochem Biophys Res Commun. 1983;110:934-939.
92. Watabe S, Ikeda T, Yago N. Activation of cathepsin D by polyanionic compounds. Bioch Molec Biol Int. 1996;39:703-710.
93. Huang JS, Tang J. Preliminary evidence for a protein-activator of cathepsin D from bovine spleen. Fed Proc. 1977;36:892 abstract 3272.
94. Masa M, Maresova L, Vondrasek J, Horn M, Jezek J, Mares M. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core. Biochemistry. 2006;45: 15474-15482.
95. Puizdar V, Turk V. Cathepsinogen D: characterization and activation to cathepsin D and inhibitory peptides. FEBS Lett. 1981;132:299-304.
96. Fusek M, Mares M, Vagner J, Voburka Z, Baudys M. Inhibition of aspartic proteinases by propart peptides of human procathepsin D and chicken pepsinogen. FEBS Lett. 1991;287: 160-162.
97. Lach T, Vihar M, Turk V. Interaction of cathepsin D and pepsin with α2-macroglobulin. In: Kostka V, ed. Aspartic proteinases and their inhibitors. Walter de Gruyter, Berlin. 1985:485-490.
98. Thomas DJ, Richards AD, Kay J. Inhibition of aspartic proteinases by α2-macroglobulin. Biochem J. 1989;259:905-907.
99. Kopitar-Jerala N, Puizdar V, Berbic S, Zavasnik-Bergant T, Turk V. A cathepsin D specific monoclonal antibody. Immunol Lett. 2001;77:125-126.
100. Weston PD. A specific antiserum to lylosomal cathepsin D. Immunology. 1969;17:421-428.
101. Avila JL, Convit J. Inhibition of leucocytic lysosomal enzymes by glicosaminoglycans in vitro. Biochem J. 1975; 152:57-64.
102. Shibata M, Koike M, Waguri S, Zhang G, Koga T, Uchiyama Y. Cathepsin D is specifically inhibited by deoxyribonucleic acids. FEBS Lett. 2002;517:281-284.
103. Tang J. Specific and irreversilde inactivation of pepsin by substrate - like epoxides. J Biol Chem. 1971;246:4510-4517.
104. Keilova H. Inhibiton of cathepsin D by diazoacetylnorleucine methyl ester. FEBS Lett. 1970;6:312-314.
105. Dumas J, Brittelli D, Chen J, Dixon B, Hatoum-Mokdad H. Synthesis and structure activity relationships of novel small molecule cathepsin D inhibitors. Bioorg Med Chem Lett. 1999;9:2531-2536.
106. Jupp RA, Dunn BM, Jacobs JW, Vlasuk G, Arcuri KE, Veber DF, Perlow DS, Payne LS, Boger J, Laszlo S, Chakravarty PK, Broekes J, Hangauer DG, Ondeyka D, Greenlee WJ, Kay J. The selectivity of statine-based inhibitors against various human aspartic proteinases. Biochem J. 1990;265:871-878.
107. Knight CG, Barrett AJ. Interaction of human cathepsin D with the inhibitor pepstatin. Biochem J. 1976;155:117-125.
108. Dash C, Kulkarni A, Dunn B, Rao M. Aspartic peptidase inhibitors: implications in drug development. Crit Rev Biochem Molec Biol. 2003;38:89-119.
109. Lenarcic B, Turk V. Tyreoglobulin type-1 domains in equistatin inhibit both papain-like cystein proteinases and cathepsin D. J Biol Chem. 1999;274:563-566.
110. Worowski K. Inhibitory komórkowych enzymów proteolitycznych. Post Biol Kom. 1976;3:51-74.
111. Huisman W, Lanting L, Doddema HJ, Bouma JMW, Gruber M. Role of individual cathepsins in lysosomal protein digestion as tested by specific inhibitors. Biochim Bioplys Acta. 1974;370:297-307.
112. Huo S, Wang J, Cieplak P, Kollman PA, Kuntz ID. Molecular dynamics and free energy analysis of cathepsin D-inhibitor interactions: insight into structure-based ligand design. J Med Chem. 2002;45:1412-1419.
113. Leung D, Abbenate G, Fairlie DP. Protease inhibitors: current status and future prospects. J Med Chem. 2000;43:305-341.
114. Rich DH. Inhibitors of aspartic proteinases. In: Barrett AJ, Salvesen G, eds. Proteinase inhibitors. Elsevier, Amsterdam. 1986:179-217.
115. Tumminello FM, Bernacki RJ, Gebbia N, Leto G. Pepstatins: aspartic proteinase inhibitors having potential therapeutic applications. Med Res Rev. 1993;13:199-208.
116. Kimura H, Tsudzuki T, Murachi T. Proteolytic degradation of hemoglobin-haptoglobin compleks by lysosomal enzymes from rat liver. J Biol. 1975;77:909-912.
117. Bohley P. Intracellular proteolysis. In: Neuberger A, Brocklehurst K, eds. Hydrolytic enzymes. Elsevier, Amsterdam. 1987:307-330.
118. Cuervo AM, Dice JF. Lysosomes, a meeting point of proteins, chaperones, and proteases. J Mol Med. 1998;76:6-12.
119. Cuervo AM, Palmer A, Rivett AJ, Knecht E. Degradation of proteasomes by lysosomes in rat liver. Eur J Biochem. 1995; 227:792-800.
120. Kominami E, Ueno T, Muno D, Katunuma N. The selective role of cathepsin B and D in the lysosomal degradation of endogenous and exogenous proteins. FEBS Lett. 1991;287: 189-192.
121. Dingle JT. The immunoinhibition of cathepsin D-mediated cartilage degradation. In: Barrett A, Dingle JT, eds. Tissue Proteinases. North-Holland Publ Co, Amsterdam. 1971:313-324.
122. Scott PG, Pearson H. Cathepsin D: specificity of peptide bond cleavage in type I collagen and effects on the type III collagen and procollogen. Eur J Biochem. 1981;114:59-62.
123. Kopitar M, Brzin J, Drobnic-Kosorek M, Babnik J, Locnikar P, Rurk V, Giraldi T, Sava G. some further characteristics of endogenous proteinase inhibitors. Acta Biol Med Germ. 1982;41:75-82.
124. Lenarcic B, Krasovec M, Ritonja A, Olafsson I, Turk V. Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett. 1991;280:211-215.
125. 1-antychumotrypsin and kallistatin hydrolysis by human cathepsin D. J Protein Chem. 2000;19:411-418.
126. Rowan AD, Mason P, Mach L, Mort JS. Rat procathepsin B. Proteolytic processing to the mature form in vitro. J Biol Chem. 1992;267:15993-15999.
127. Van der Stappen JWJ, Williams AC, Maciewicz RA. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer. 1996;67:547-554.
128. Wiederanders B, Kirschke H. The processing a cathepsin L precursor in vitro. Arch Biochem Biophus. 1989;272:516-521.
129. Darby NJ, Smyth DG. Endopeptidases and prohormone processing. Biosci Rep. 1990;10:1-14.
130. Kageyama T. Rabbit procathepsin E and cathepsin E. Eur J Biochem. 1993;216:717-728.
131. Fruitier I, Garreau I, Piot JM. Cathepsin D is a good candidate for the specific release of stable hemorphin from hemoglobin in vivo: VV-hemorphin-7. Biochem Biophys Res Commun. 1998;246:719-724.
132. Garreau I, Cucumel K, Dagouassat N, Zhao P, Gupo A, Piot JM. Hemorphin peptides are released from hemoglobin by cathepsin D. Radioimmunoassay against the C-part of V-V-hemorphin-7: an alternative assay for the cathepsin D activity. Peptides. 1997;18:293-300.
133. Reeves JP. The mechanism of lysosomal acidification. In: Dingle JT, Dean RT, Sly W, eds. Lysosomes in biology and pathology. Elsevier, Amsterdam. 1984:175-199.
134. Kazakova OV, Orekhovich V. Some properties of cathepsins chemically fixed to carriers. Int J Pept Protein Res. 1975; 7:23-29.
135. Diment S, Leech MS, Stahl PD. Cathepsin D in membrane-associated in macrophage endosomes. J Biol Chem. 1988; 263:6901-6907.
136. Marciniszyn J, Hartsuck JA, Tang J. Mode of inhibition of acid proteases by pepstatin. J Biol Chem. 1976;251:7088-7094.
137. Karwowska A, Chlabicz M. Bovine globin as substrate of cathepsin D. In preparation.
138. Roth JA, Losty K, Wierbick E. Assay of proteolytic enzyme activity using a 14C-labelet hemoglobin. Anal Biochem. 1971;42:214-221.
139. Lebez D, Kopitar M, Turk V, Kregar I. Comparison of properties of cathepsin D and E with some new cathepsine. In: Barrett AJ, Dingle JT, eds. Tissue proteinases. Nrth-Holland Publ Co, Amsterdam. 1971:167-176.
140. Dunn BM, Jiminez M, Parten BF, Valler CE, Rolph J, Kay J. a systematic series of synthetic chromophoric substrates for aspartic proteinases. Biochem J. 1986;237:899-906.
141. Gulnik S, Suvorov L, Majer P, Collins J, Kane B, Johnson DG, Erickson J. Design of sensitive fluorogenic substrates for human cathepsin D. FEBS Lett. 1997;413:379-384.
142. Pimento DC, Oliveira A, Juliano MA, Juliano L. Sunstrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin. Biochim Biophys Acta. 2001;1544:113-122.
143. Yasuda Y, Kageyama T, Akamine A, Shibata M, Kominami E, Uchiyama Y, Yamamoto K. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D. J Biochem. 1999;125:1137-1143.
144. Turk V, Lah T, Kregar I. Cathepsin D, cathepsin E. In: Bergmeyer HU, ed. Methods of enzymatic analysis. Verlag Chemie, Weinheim. 1984:211-222.
145. Knight CG. Active site titration of peptidases. Meth Enzymol. 1995;248:85-101.
146. Brouillet JP, Spyratos F, Hacene K, Fauque J, Freiss G, Dupont F, Maudelonde T, Rochefort H. Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D. Eur J Cancer. 1993;29A:1248-1251.
147. Ravdin PM, Tandon ASK, Allred DC. Chathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol. 1994;12:468-474.
148. Reid WA, Valler MJ, Kay J. Immunolocalisation of cathepsin D in normal and neoplastic human tissues. J Clin Pathol. 1986;39:1323-1330.
149. Roger P, Montcourrier P, Maudelonde T, Brouillet JP, Pages A, Laffargue F, Rochefort H. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages. Correlation with cytosolic assay. Human Pathol. 1994;25: 863-871.
150. Sasaki H, Saku Y, Kato K, Yamamoto K. Quantitation and immunohistochemical localization of cathepsin E and D in rat tissues and blood cells. Biochim Biophys Acta. 1989;991: 367-375.
151. Matthews ITW, Decker RS, Knight CG. Bimane-labeled pepstatin, a fluorescent probe for the subcellular location of cathepsin D. Biochem J. 1981;199:611-617.
152. Yamato S, Hirabayashi Y, Sigihara H. An improved procedure for the histochemical demonstration of cathepsin D by the mercury-labeled pepstatin method. Stain Technol. 1984; 59:113-120.
153. Yamato S, Hirabayashi Y, Sugihara H, Uematsu H. Electron microscopic visualization of cathepsin D using mercury-labeled pepstatin as an enzyme inhibitor. J Histochem Cytochem. 1982;30:1228-1234.
154. Kay J, Tatnell PJ. Cathepsin E. In: Barrett AJ, Rawling ND, Woessner JF, eds. Handbook of proteolytic enzymes. Elsevier, Amsterdam. 2004;1:33-38.
155. Ng KKS, Petersen MM, Charney MM, Garen C, Zalatoris JJ, Rao-Naik C, Dunn BM, Martzen MR, Peansky RJ, James MNG. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3. Nat Struct Biol. 2000;7:653-657.
156. Willenbucher J, Hofle W, Lucius R. The filarial antigens Av33/Ov33-3 show stricking similarities to the major pepsin inhibitor from Ascaris suum. Mol Biochem Parasitol. 1993; 57:349-351.
157. Yamamoto K, Kamata O, Katsuda N, Kato K. Immunochemical difference between cathepsin D and cathepsin E-like enzyme from rat spleen. J Biochem. 1980;87:511-516.
158. Berchem G, Glondn M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E. Cathepsin D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene. 2002;21:5951-5955.
159. Chwieralski CE, Wlte T, Buhling F. Cathepsin-regulated apoptosis. Apoptosis. 2006;11:143-150.
160. Cybulski M, Berbeć H. rola katepsyny D w progresji nowotworowej. Post Biochem. 2001;47:224-231.
161. Davidson Y, Gibbons L, Pritchard A. Genetic associations between cathepsin D exon 2 C→T polymorphism and Alzheimer's disease, and pathological correlations with genotype. J Neurol Neurosurg Psychiat. 2006;77:515-517.
162. Fusek M, Vetvicka V. Dual role of cathepsin D: ligand and protease. Biomed Papers. 2005;149:43-50.
163. Heinrich M, Neumeyer J, Jakob M, Halls C, Tchikov V, Winoto-Morbach S, Wickel M, Schneider-Brachert W, Trauzoll A, Hethke A, Schulze C. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 2004;11:550-563.
164. Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastas. 2004;21:91-106.
165. Liaudet-Coopman E, Beaujonin M, Derocq D, Garcia M, Glondu-Lassis M, Laurent-Matha V, Prebois C, Rochefort H, Vigon F. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 2006;237:167-179.
166. Minarowska A, Minarowski K, Karwowska A, Gacko M. Regulatory role of cathepsin D in apoptosis. Folia Histochem Cytobiol. 2007;45:159-163.
167. Roberg K, Kaged K, Ollinger K. Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am J Pathol. 2002;16:89-96.
168. Warwas M, Taurowska E. Znaczenie katepsyny D w diagnostyce choroby nowotworowej. Post Hig Med. Dośw. 1993;47:277-288.
169. Komai T, Kawabata C, Amano M, Lee BR, Ichima E. Tadarepsin, a new cathepsin D from hepatopancreas of Japanese common squid (Todarodes pacificus). Biochem Physiol Part B. 2004;137:373-382.
170. Weston PD, Poole AR. Antibodies to enzymes and their uses, with specific reference to cathepsin D and other lysosomal enzymes. In: Dingle JT, ed. Lysosomes in biology and pathology. North Holland Elsevier, Amsterdam. 1973;3:425-464.
171. Baldwin ET, Bhat TN, Gulnik S, Hosur MV, Sowder RC 2nd, Cachau RE, Collins J, Silva AM, Erickson JW. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc Natl Acad Sci USA. 1993;15;90(14):6796-800.
172. Lee AY, Gulnik SV, Erickson JW. Conformational switching in an aspartic proteinase. Nat Struct Biol. 1998;5(10):866-71.